{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:18:07Z","timestamp":1758154687602,"version":"3.44.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cjca.2025.05.012","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:52:15Z","timestamp":1748083935000},"page":"1466-1468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial Commentary to The Role of Myocardial Radiofrequency Ablation in the Management of Obstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"41","author":[{"given":"Josef","family":"Veselka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.05.012_bib1","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.012_bib2","first-page":"1457","article-title":"Comparison of percutaneous endocardial septal radiofrequency ablation with alcohol septal ablation in treating hypertrophic obstructive cardiomyopathy","volume":"41","author":"Tian","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.012_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for obstructive hypertrophic cardiomyopathy (EXPLORER-HCM)","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.05.012_bib4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.012_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pcad.2023.08.003","article-title":"Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy","volume":"80","author":"Mehra","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2025.05.012_bib6","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.amjcard.2014.07.075","article-title":"Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient sample 1998-2010)","volume":"114","author":"Panaich","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.012_bib7","first-page":"16","article-title":"Effects of institutional experience on outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"34","author":"Veselka","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.012_bib8","first-page":"833","article-title":"Interventions in hypertrophic obstructive cardiomyopathy","volume":"40","author":"Ding","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.012_bib9","first-page":"860","article-title":"Mitral valve interventions for hypertrophic obstructive cardiomyopathy","volume":"40","author":"Shuvy","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.012_bib10","first-page":"1303","article-title":"Personalized treatment of severe obstructive hypertrophic cardiomyopathy: combining septal reduction therapy and myosin inhibitors","volume":"41","author":"Veselka","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.012_bib11","first-page":"1622","article-title":"Outcomes of alcohol septal ablation in patients with severe left ventricular outflow tract obstruction: a propensity score matching analysis","volume":"39","author":"Veselka","year":"2023","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X2500371X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X2500371X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:27:44Z","timestamp":1758133664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X2500371X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0828282X2500371X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.05.012","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial Commentary to The Role of Myocardial Radiofrequency Ablation in the Management of Obstructive Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.05.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}